Valuation: Cipla Limited

Market Cap 1,176B 12.35B 10.8B 9.91B 9.24B 17.53B 17.82B 119B 46.26B 577B 46.39B 45.38B 1,988B P/E 2027 *
28x
P/E 2028 * 22.9x
Enterprise Value 1,077B 11.32B 9.89B 9.08B 8.47B 16.05B 16.33B 109B 42.37B 528B 42.49B 41.57B 1,821B EV / Sales 2027 *
3.47x
EV / Sales 2028 * 3.03x
Free-Float
68.88%
Yield 2027 *
0.86%
Yield 2028 * 0.97%
1 day-0.05%
1 week+1.26%
Current month-0.64%
1 month+4.73%
3 months+21.75%
6 months-2.99%
Current year-3.66%
1 week 1,441.5
Extreme 1441.5
1,490.1
1 month 1,341.1
Extreme 1341.1
1,490.1
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 996.5
Extreme 996.5
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
President - 2026-05-17
Director of Finance/CFO - 2022-08-15
Director TitleAgeSince
Chairman 90 1972-07-20
Director/Board Member 72 2014-07-24
Director/Board Member 71 2021-06-29
Date Insider Type Main position Quantity % Market Cap.
24-08-21Sell 2,000 0.0002%
24-08-13Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%+1.26%-3.94%+43.46% 12.38B
+0.26%-0.18%+12.22%+77.92% 47.1B
+8.72%+6.67%+69.77%+119.98% 34.57B
-0.85%+0.05%+9.71%+88.63% 11.64B
+0.78%-1.91%+33.16%+121.55% 8.87B
-0.08%-0.25%+22.32%+44.60% 7.1B
+1.44%+2.21%+56.02%-7.83% 6.85B
+1.58%+0.71%+25.18%+224.85% 6.42B
+6.55%+16.01%-27.50%+16.83% 5.61B
-0.07%+2.75%+33.67%+126.16% 4.4B
Average +1.83%+2.26%+23.06%+85.61% 14.49B
Weighted average by Cap. +2.53%+0.41%+27.90%+88.46%

Financials

2027 *2028 *
Net sales 311B 3.26B 2.85B 2.62B 2.44B 4.63B 4.71B 31.53B 12.22B 152B 12.25B 11.99B 525B 347B 3.64B 3.18B 2.92B 2.73B 5.17B 5.25B 35.19B 13.64B 170B 13.68B 13.38B 586B
Net income 41.98B 441M 385M 354M 330M 625M 636M 4.26B 1.65B 20.59B 1.66B 1.62B 70.95B 51.42B 540M 472M 433M 404M 766M 779M 5.22B 2.02B 25.22B 2.03B 1.98B 86.9B
Net Debt -98.76B -1.04B -906M -832M -776M -1.47B -1.5B -10.02B -3.88B -48.44B -3.9B -3.81B -167B -125B -1.31B -1.15B -1.05B -982M -1.86B -1.89B -12.68B -4.91B -61.29B -4.93B -4.82B -211B
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
26-07-02 1,456.00 -0.05% 731,416
26-07-01 ₹1,456.70 -0.59% 753,439
26-06-30 ₹1,465.40 +0.78% 2,818,077
26-06-29 ₹1,454.10 +0.97% 4,162,869
26-06-25 ₹1,440.10 +0.15% 1,217,683
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,456.00INR
Average target price
1,463.62INR
Spread / Average Target
+0.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock